Short‐term efficacy and safety of new biological agents targeting the interleukin‐23–T helper 17 pathway for moderate‐to‐severe plaque psoriasis: a systematic review and network meta‐analysis (original) (raw)
You do not currently have access to this article.
Purchase
Short-term Access
To purchase short-term access, please sign in to your personal account above.
Don't already have a personal account? Register
Short‐term efficacy and safety of new biological agents targeting the interleukin‐23–T helper 17 pathway for moderate‐to‐severe plaque psoriasis: a systematic review and network meta‐analysis - 24 Hours access
EUR €58.00
GBP £50.00
USD $62.00
Rental
This article is also available for rental through DeepDyve.
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals